Summary Sysmex Corp (Sysmex) is a supplier of medical devices.It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management.
The company offers diagnostic instruments, reagents and laboratory information systems to clinical laboratories for testing.The solutions that the company offers include haematology, haemostasis, urinalysis analyzers.
It conducts research and development at its facilities in Japan, New Zealand, France, Germany and the US.The company operates along with its subsidiaries in the Americas, Europe, Middle East, Africa and Asia Pacific.
Its products are used by medical institutions. Sysmex is headquartered in Hyogo, Japan.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Sysmex Corp - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Our reports have been used by over 10K customers, including:
The global vaginal specula market is expected to grow from US$ 955.66 million in 2022 to US$ 1,180.41 million by 2028; it is estimated to grow at a CAGR of 3.6% from 2022 to 2028. A vaginal speculum is a medical device typically used to examine vaginal orifices by doctors and medical practitioners. It is either a metal-based or non-metal...
The global Tissue Diagnostics market is growing at a CAGR of 6.6% during and it is expected to reach USD 7.3 billion by 2027 from USD 5.3 billion in 2022, during the forecast period. The expansion of this market is majorly due to rising prevalence of neoplastic cases as well as high demand of oncology screening, However, Lack of skilled professionals...
1417 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
The Brazil diagnostic labs market is projected to reach US$ 24,334.07 million by 2028 from US$ 13,367.60 million in 2022; it is expected to grow at a CAGR of 10.5% from 2022 to 2028. Rising prevalence of ageing-related diseases and chronic diseases drives the overall market growth. Use of Artificial Intelligence (AI) and analytics in...
460 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
The Global Coronary Heart Disease Diagnostic Imaging Devices Market size is expected to reach $2.1 billion by 2028, rising at a market growth of 6.7% CAGR during the forecast period. Coronary Artery Disease, also called CAD, is a cardiovascular disease caused by diminished or missing blood flow in the arteries that encircle and supply...
250 pages •
By The Business Research Company
• May 2022
Major players in the smart pills market are Medtronic Plc., Olympus Medical Technology, CapsoVision, Inc., Novartis AG, Proteus Pharmaceuticals, Philips Healthcare, Microchips, Bio-Images Drug Delivery (BDD) Limited, Given Imaging, Inc., and Vitality. The global smart pills market is expected to grow from $4.03 billion in 2021 to $4.48...
303 pages •
By The Business Research Company
• Jul 2022
Influenza Diagnostics Global Market Opportunities And Strategies To 2031 provides the strategists; marketers and senior management with the critical information they need to assess the global influenza diagnostics market as it emerges from the COVID-19 shut down. Description: Where is the largest and fastest growing...
The STD Diagnostics Market was valued at approximately USD 13,154.9 million in 2021 and is expected to reach USD 21,759.9 million by 2026, registering a CAGR of nearly 8.7% during the forecast period, 2022-2027. The COVID-19 pandemic is expected to have a significant impact on sexually transmitted disease diagnostics. According to the...
The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving the infectious disease diagnostics market growth. The market growth is attributed...
Infectious Disease
Diagnostics
World
APAC
Europe
Diagnostic Revenue
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.